(Q36885004)

16 August 2017

1 reference

title

Clinical spectrum of primary hyperparathyroidism: evolution with changes in medical practice and technology (English)

1 reference

16 August 2017

Clinical spectrum of primary hyperparathyroidism: Evolution with changes in medical practice and technology (English)

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

18 November 2022

1 reference

primary hyperparathyroidism

1 reference

based on heuristic

inferred from title

Orthopedics and sports medicine

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

18 November 2022

1

Heath H 3rd

1 reference

16 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1763671

18 November 2022

publication date

1 October 1991

1 reference

full work available at URL

16 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbmr.5650061415

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

https://onlinelibrary.wiley.com/doi/full/10.1002/jbmr.5650061415

18 November 2022

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Journal of Bone and Mineral Research

18 November 2022

published in

1 reference

16 August 2017

volume

6 Suppl 2

1 reference

16 August 2017

page(s)

S63-70; discussion S83-4

1 reference

Back Pain and Vertebral Crush Fractures: An Unemphasized Mode of Presentation for Primary Hyperparathyroidism

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.5650061415

The Story of Hyperparathyroidism at the Massachusetts General Hospital

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

18 November 2022

3

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Primary hyperparathyroidism: changes in the pattern of clinical presentation

18 November 2022

4

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Therapeutic radiation and hyperparathyroidism. A case-control study in Rochester, Minn

18 November 2022

5

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood

18 November 2022

6

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Clinical findings in patients with hypercalcaemia. A final investigation based on biochemical screening

18 November 2022

7

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

The effect of multiphasic biochemical screening on the diagnosis of primary hyperparathyroidism

18 November 2022

8

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Parathyrin and calcitonin stimulate cyclic AMP accumulation in cultured murine brain cells.

18 November 2022

11

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Cerebral Vascular Adenylate Cyclase: Evidence for Coupling to Receptors for Vasoactive Intestinal Peptide and Parathyroid Hormone

18 November 2022

12

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Effect of parathyroid hormone on rat heart cells

18 November 2022

13

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Parathyroid Hormone Inhibitors: Comparison of Biological Activity in Bone- and Skin-Derived Tissue*

18 November 2022

14

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

cAMP response of vascular smooth muscle cells to bovine parathyroid hormone

18 November 2022

15

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Effects of synthetic analogs and fragments of bovine parathyroid hormone on adenosine 3',5'-monophosphate level, ornithine decarboxylase activity, and glycosaminoglycan synthesis in rabbit costal chondrocytes in culture: structure-activity relations

18 November 2022

17

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity

18 November 2022

18

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat.

18 November 2022

19

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Effect of parathyroid hormone on erythropoiesis

18 November 2022

20

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay

18 November 2022

22

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Increased fracture risk in hypercalcemia. Bone mineral content measured in hyperparathyroidism

18 November 2022

26

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Skeletal disease in primary hyperparathyroidism

18 November 2022

27

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Expanding indications for early parathyroidectomy in the elderly female

18 November 2022

28

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Indications for surgery in the elderly patient with primary hyperparathyroidism

18 November 2022

29

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Patient benefit in discovering occult hyperparathyroidism

18 November 2022

30

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Primary hyperparathyroidism: the case for medical management.

18 November 2022

33

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course

18 November 2022

34

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Primary hyperparathyroidism: changes in trabecular bone remodeling following surgical treatment--evaluated by histomorphometric methods

18 November 2022

38

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Bone mineral content in patients with primary hyperparathyroidism without radiological evidence of skeletal changes

18 November 2022

39

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Photon absorptiometric analysis of bone density in primary hyperparathyroidism

18 November 2022

40

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Partially reversible osteopenia after surgery for primary hyperparathyroidism

18 November 2022

42

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Bone mineral changes in primary hyperparathyroidism

18 November 2022

43

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Bone mineral density and surgical treatment of primary hyperparathyroidism

18 November 2022

44

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism

18 November 2022

46

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Reversible hypertension in primary hyperparathyroidism--pre- and posteroperative blood pressure in 75 cases

18 November 2022

47

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy

18 November 2022

48

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Arterial hypertension and primary hyperparathyroidism. Incidence and follow-up after parathyroidectomy

18 November 2022

49

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Parathyroid hypertension. A reversible disorder

18 November 2022

50

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

Clinical indications for bone mass measurements. A report from the Scientific Advisory Board of the National Osteoporosis Foundation

18 November 2022

51

1 reference

https://api.crossref.org/works/10.1002/JBMR.5650061415

18 November 2022

Identifiers

1 reference

16 August 2017

1 reference